AB Skincare Acne Spot Treatment
- Manufacturer
- Norris Ltd
- Effective date
- 2018-09-27
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-05-31 22:56:54
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
WARNINGS SECTION
For external use ONLY. Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. Avoid unnessary sun exposure and use a sunscreen. Avoid contact with eyes, lips and mouth. Avoid contact with hair, dyed fabrics, which may be bleached by this product. Skin irritation may occur characterized by redness, burning, itching, peeling or possibly swelling, Irritation may be reduced by using the product less frequently or in lower concentration.
DO NOT USE If you have very sensitive skin or are sensitive to Benzoyl Peroxide. STOP USE AND ASK DOCTOR if irritation becomes severe.
INSTRUCTIONS FOR USE SECTION
Clean the skin thoroughly before applying this product. Cover the entire affected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application nto once a day or every other day. If going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and and ask a doctor.
GERIATRIC USE SECTION
Keep tightly closed and protect product from freezing or becoming excessively hot. Please refer any questions to 503.887.7087 or
www.abskincare.com
DOSAGE & ADMINISTRATION SECTION
One application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness occurs, reduce daily aplication to once a day or every other day.
INACTIVE INGREDIENT SECTION
Water, carbomer, Sodium Dioctyl Sulfosuccinate, Tetrasodium Glutamate Diacetate, Propylene Glycol, Sodium Citrate, Dimethicone, PEG_40, Silica, Sorbitan Stearate, Xanthan Gum
INDICATIONS & USAGE SECTION
If irritation or sensitivy develops stop use of both products and ask a doctor
OTC - PURPOSE SECTION
For the treatment of acne
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
OTC - ACTIVE INGREDIENT SECTION
Benzoyll Peroxide 10%
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0863724000400 | GTIN-13: 0863724000400 EAN-13: 0863724000400 GTIN-12: 863724000400 UPC-A: 863724000400 GTIN storage (14 digits): 00863724000400 | JULY 13- SPOT TREATMENT CARTON LABEL .jpg |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a46239a7-5963-4008-8cbb-6b9000f497eb | Product name | 1 | 20250721 |
| b382b4e1-6b48-45f6-bffc-e61b00b0ce19 | Product name | 3 | 20250317 |
| d9d61457-6a5a-41fc-b418-e5479a2904b7 | Product name | 2 | 20230303 |
| 32012d5c-25ac-49c7-9d4c-1313177fff7c | Product name | 1 | 20230112 |
| 13e7e7e3-e885-4c79-af6d-dad1aedbb06e | Product name | 1 | 20220128 |
| 4a7d44fe-774d-404b-aad0-8a90fe78375a | Product name | 4 | 20211025 |
| 3f45980c-c196-47e5-0e5e-48b7c57327c5 | Product name | 5 | 20200428 |
| d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27b | Product name | 3 | 20200203 |
| ee5c6de5-d9cd-454f-b250-7b19e5cf2992 | Product name | 4 | 20190619 |
| ad75fcfd-a339-42a1-9c60-43ba2c654cfa | Product name | 1 | 20170810 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 71563-0400-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-bb99-f424-e053-dadaa90a57ce | 5437ccae-587a-6be4-e054-00144ff88e88 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71563-0400-1 | AB Skincare Acne Spot Treatment | 28 g in 1 TUBE | CREAM | 28 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71563-0400 | AB SKINCARE ACNE SPOT TREATMENT (BENZOYL PEROXIDE) CREAM [NORRIS LTD] | 2 | Legacy NDC, 1 package rows | 20180927_5437ccae-587a-6be4-e054-00144ff88e88.zip |
Products#
Every source-derived product name is available through these pages.
- AB Skincare Acne Spot Treatment
- Benzoyl Peroxide
- METHOXY PEG-40
- XANTHAN GUM
- CARBOXYPOLYMETHYLENE
- WATER
- DIMETHICONE 1000
- SORBITAN MONOSTEARATE
- SODIUM CITRATE
- DOCUSATE SODIUM
- TETRASODIUM GLUTAMATE DIACETATE
- 2-PHENYLPROPANAL PROPYLENE GLYCOL ACETAL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 71563-0400 | 71563-0400-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BENZOYL PEROXIDE | W9WZN9A0GM | ACTIB |
| METHOXY PEG-40 | 6AXS45P1QU | IACT |
| XANTHAN GUM | TTV12P4NEE | IACT |
| CARBOXYPOLYMETHYLENE | 0A5MM307FC | IACT |
| WATER | 059QF0KO0R | IACT |
| DIMETHICONE 1000 | MCU2324216 | IACT |
| SORBITAN MONOSTEARATE | NVZ4I0H58X | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
| DOCUSATE SODIUM | F05Q2T2JA0 | IACT |
| TETRASODIUM GLUTAMATE DIACETATE | 5EHL50I4MY | IACT |
| 2-PHENYLPROPANAL PROPYLENE GLYCOL ACETAL | 1ZRR9A405A | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 76df73c6-0daf-fc83-e053-2991aa0a2b0e | 5437ccae-587a-6be4-e054-00144ff88e88 | 2018-09-27 | Warnings | 76df73c6-0daf-fc83-e053-2991aa0a2b0e 5437ccae-587a-6be4-e054-00144ff88e88 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

